Accredited InvestorsEmployee ShareholdersInstitutionsPrivate Companies Who We Serve Trading and Investing Data Solutions Private Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Browse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunities​Forge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All Insights Private Market Reports Market Insights Buying and Selling Pre-IPO​ All Reports​Private Market UpdatesForge Investment OutlookStartup News and Trends​Private Market Data and Analytics​Tech IPO Calendar for 2024​Private Market Explained​Buying Pre-IPO Shares​Selling Pre-IPO SharesGlossaryVideosFAQsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
Solutions
Insights
About
Who We Serve
Solutions
Trading and Investing
Institutional Trading
Individual Investing
Data Solutions
Private Asset Custody
Self-Directed IRA
Insights
Private Market Reports
Market Insights
Buying and Selling Pre-IPO​
About
Log In
Sign Up
Secondary Marketplace / Trade Private Companies / Buy and Sell Totus Medicines Stock

Totus Medicines Stock

www.totusmedicines.comHealthcare / BioTech & PharmaFounded: 2020

Totus Medicines, founded in 2020, is a biotechnology research company whose Totus Platform strives to discover drugs for hard-to-treat diseases. Using a covalent molecule approach to identify undruggable targets, along with machine learning and sophisticated cellular examination, their platform aims to uncover drugs that can be used to treat advanced cancer conditions, heart disease, and brain degeneration. Totus has also developed a pipeline of oncology initiatives that are designed put cancer treatment at the forefront. Totus Medicines is headquartered in Emeryville, California.

Buy or sell Totus Medicines stockLearn more about Totus Medicines IPO

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Totus Medicines, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Totus Medicines’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Totus Medicines.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Totus Medicines investors also invested in these private companies

DHVC
DCVC Bio
Camford Capital
Northpond Ventures
Social Impact Capital

Team

Management Team

Daisy Chhokar
Chief People Officer
Neil Dhawan Ph.D
Co-Founder, Head of Research and Development & Chief Scientific Officer
Tom Knudsen
Chief Business Officer
Jimmy Blair Ph.D
Co-Founder & Vice President of Platform Innovation Chemical Biology
Jason Pontin
Co-Founder
Ovid Trifan MD
Chief Medical Officer
Nassim Usman Ph.D
Chief Executive Officer & President
John Davies Ph.D
Chief Data Officer

Board Members

Ali Farahanchi
DHVC
Connor McDermott
Northpond Ventures
John Hamer Ph.D
DCVC Bio
Kiersten Stead Ph.D
DCVC Bio
Steve Liapis Ph.D
Northpond Ventures

Totus Medicines stock FAQs

plusminus

Can you buy Totus Medicines stock?

As Totus Medicines is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Totus Medicines, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy Totus Medicines stock?

To invest in a private company like Totus Medicines through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Totus Medicines stock?

Yes, you may be able to sell your Totus Medicines stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Totus Medicines stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Totus Medicines stock on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is Totus Medicines a public company?

No, Totus Medicines is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Totus Medicines’ stock price?

Totus Medicines is a privately held company and therefore does not have a public stock price. However, you may access Totus Medicines’ private market stock price with Forge Data.
plusminus

What is Totus Medicines’ stock ticker symbol?

Totus Medicines does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Totus Medicines in the BioTech & Pharma sector

Colossal Biosciences
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B
Altos Labs
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$6.33B
ADARx Pharmaceuticals
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$827.77MM
Cytonics
Sector
Healthcare / BioTech & Pharma
 
 
AI Therapeutics
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$110MM
Egenesis
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$333.77MM
Apnimed
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$366.58MM
Pendulum Therapeutics
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$308.05MM
BillionToOne
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.25B
FinSMEs 12/17/2023

Totus Medicines Closes $66M Series B Funding

Totus Medicines, an Emeryville, CA-based small molecule drug discovery and development company using covalent libraries and AI tools, closed a $66M Series B financing. The round was led by DCVC Bio with participation from North Pond Ventures, Camford Capital, and the Regents of the University of Minnesota. Proceeds from the Series B financing will be used to advance Totus’ clinical program, expand the pipeline, and evolve the platform.
Browse More Insights
Trending Companies

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.